Aquestive Therapeutics AQST
NASDAQ AQST
$4.68 -0.07 (-1.58%)
As of: Sep 29, 2026 · 3:59 PM EDT

Aquestive Therapeutics (AQST) FCF Margin (2017 - 2026)

Updated

Aquestive Therapeutics (AQST) posted FCF Margin of -69.85% for Q2 2026, up 10.33 percentage points from -80.19% a year earlier and up 33.00 percentage points from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) FCF Margin (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Aquestive Therapeutics was -84.95%, up 28.39 percentage points year-over-year; for FY2025, it came in at -118.97%, down 56.57 percentage points from FY2024.

  • Annual FCF Margin shows a five-year change of -18.69 percentage points (FY2020 to FY2025).
  • In prior years, Aquestive Therapeutics' FCF Margin was -62.40% in FY2024 (-47.82 pp), -14.58% in FY2023 (+8.16 pp), -22.74% in FY2022 (+43.93 pp) and -66.67% in FY2021 (+33.60 pp).
  • Quarterly FCF Margin has run from a low of -269.90% in Q1 2025 to a high of 79.16% in Q1 2023 over five years.
  • On a year-over-year basis, FCF Margin increased in two of the last eight quarters, with an average year-over-year change of -20.11 percentage points.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q1 2023, with a gain of 198.04 percentage points; the weakest was Q1 2025, with a drop of 183.50 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was -102.85% (Q1 2026), -65.72% (Q4 2025) and -100.60% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Aquestive Therapeutics 596.18 Mn 136.72 Mn 9.80 Mn -69.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -69.85%
Mar 31, 2026 -102.85%
Dec 31, 2025 -65.72%
Sep 30, 2025 -100.60%
Jun 30, 2025 -80.19%
Mar 31, 2025 -269.90%
Dec 31, 2024 -54.81%
Sep 30, 2024 -88.32%
Jun 30, 2024 -35.03%
Mar 31, 2024 -86.39%
Dec 31, 2023 -37.54%
Sep 30, 2023 -19.21%
Jun 30, 2023 -65.95%
Mar 31, 2023 79.16%
Dec 31, 2022 78.54%
Sep 30, 2022 22.61%
Jun 30, 2022 -54.57%
Mar 31, 2022 -118.88%
Dec 31, 2021 -77.58%
Sep 30, 2021 -68.85%
API Access

Aquestive Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=AQST&period=max&api_key=YOUR_API_KEY